Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
OMI 0.315 +0.0% BMM 3.80 +0.0% CGD 0.630 +10.5% OCG 0.275 −1.8% CAMB 0.980 −2.0% HMR 0.610 −1.6% GOFL 0.025 +0.0% SIG 1.02 −1.0% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.800 −12.1% SMY 0.290 +23.4% SAG 1.02 +0.0% OMI 0.315 +0.0% BMM 3.80 +0.0% CGD 0.630 +10.5% OCG 0.275 −1.8% CAMB 0.980 −2.0% HMR 0.610 −1.6% GOFL 0.025 +0.0% SIG 1.02 −1.0% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.800 −12.1% SMY 0.290 +23.4% SAG 1.02 +0.0%

Healthcare

Page 41
  1. Mar 30, 2026 · 07:30 · MRVL · Material +

    Non-Dilutive Capital Fuels Phase I Leap as Patent Moat Tightens

    Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

    01
  2. Mar 30, 2026 · 07:19 · APLI · Neutral

    Appili Touts Non-Dilutive Grants as Cash Burn Outpaces Micro-Cap Equity Raises

    Appili Therapeutics to Exhibit at World Vaccine Congress Washington

    02
  3. Mar 30, 2026 · 07:01 · VIVI · Routine +

    TempraMed’s Panama LOI Adds Another Geographic Checkbox as Stock Tests Multi-Month Lows Amid Unproven Commercial Traction

    TempraMed Signs LOI for Distribution Agreement in Panama, Expanding Central American Exposure

    03
  4. Mar 30, 2026 · 06:03 · ARCH · Neutral

    Arch Biopartners Closes $600K Lifeline as Stock Tests 52-Week Lows Amid Dilution and Trial Rollout

    Arch Biopartners Arranges Non-Brokered Private Placement

    04
  5. Mar 30, 2026 · 03:05 · BNXT · Routine +

    BioNxt Pivots to GLP-1 Thin-Film Race as Cladribine Trials Stall and Cash Burn Looms

    BioNxt Advances Semaglutide as First Application of Broad GLP-1 ODF Platform Strategy

    05
  6. Mar 27, 2026 · 15:15 · PRN

    Profound talks up Tulsa procedure milestone in Texas

    Profound talks up Tulsa procedure milestone in Texas

    06
  7. Mar 27, 2026 · 10:15 · VPT

    MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

    MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

    07
  8. Mar 27, 2026 · 09:30 · VPT

    How Decentralized AI is Unlocking Value in Cardiac Diagnostics

    How Decentralized AI is Unlocking Value in Cardiac Diagnostics

    08
  9. Mar 27, 2026 · 08:10 · QNTM

    Quantum Biopharma's 2025 Audited Year End Financial Results Maintain 'No Going Concern' Status

    Quantum Biopharma's 2025 Audited Year End Financial Results Maintain 'No Going Concern' Status

    09
  10. Mar 27, 2026 · 07:45 · PRN

    Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure(TM) Milestone

    Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure(TM) Milestone

    10
  11. Mar 27, 2026 · 07:00 · MSCL

    Satellos Reports 2025 Financial Results and Highlights Recent Company Progress

    Satellos Reports 2025 Financial Results and Highlights Recent Company Progress

    11
  12. Mar 26, 2026 · 23:46 · ALGO

    Light AI reports Financial Results for Three Months and Year ended December 31, 2025

    Light AI reports Financial Results for Three Months and Year ended December 31, 2025

    12
  13. Mar 26, 2026 · 17:34 · PHRM

    Pharmather applies for provisional PatchPrint patent

    Pharmather applies for provisional PatchPrint patent

    13
  14. Mar 26, 2026 · 17:17 · QNTM

    Quantum Biopharma appoints Napoli as trial investigator

    Quantum Biopharma appoints Napoli as trial investigator

    14
← Newer Older →